Search research articles
Contact Us
Filters
Showing results (271-280 of 369) with videos related to
Page
of 37
Sort By:
Journal of Experimental & Clinical Cancer Research : CR
|
March 24, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment
Nadja I Lorenz, Benedikt Sauer, Hans Urban, et al.
British Journal of Cancer
|
March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma
F Strassheimer, P Elleringmann, G Ludmirski, et al.
Acta Neuropathologica
|
October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entity
Ulrich Herrlinger, David T W Jones, Martin Glas, et al.
Oncotarget
|
October 31, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Patrick N Harter, Simon Bernatz, Alexander Scholz, et al.
Neuro-Oncology
|
February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Acta Neuropathologica
|
January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity
Ulrich Herrlinger, David T W Jones, Martin Glas, et al.
Acta Neuropathologica Communications
|
March 2, 2018
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival
P S Zeiner, J Zinke, D J Kowalewski, et al.
Journal of Neuro-Oncology
|
August 19, 2009
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
Gregor Dresemann, Michael Weller, Mark A Rosenthal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
Borderline Findings in <i>O</i>-(2-[<sup>18</sup>F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
Karl-Josef Langen, Gabriele Stoffels, Christian P Filss, et al.
American Journal of Medical Genetics
|
January 1, 1981
The dup(3q) syndrome: report of eight cases and review of the literature
P Steinbach, W N Adkins, H Caspar, et al.
Page
of 37
Search research articles
Search
Showing results (271-280 of 369) with videos related to
Sort By:
Page
of 37
Journal of Experimental & Clinical Cancer Research : CR
|
March 24, 2025
AMP-activated protein kinase mediates adaptation of glioblastoma cells to conditions of the tumor microenvironment
Nadja I Lorenz, Benedikt Sauer, Hans Urban, et al.
British Journal of Cancer
|
March 19, 2025
CAR-NK cell therapy combined with checkpoint inhibition induces an NKT cell response in glioblastoma
F Strassheimer, P Elleringmann, G Ludmirski, et al.
Acta Neuropathologica
|
October 24, 2015
Gliomatosis cerebri: no evidence for a separate brain tumor entity
Ulrich Herrlinger, David T W Jones, Martin Glas, et al.
Oncotarget
|
October 31, 2015
Distribution and prognostic relevance of tumor-infiltrating lymphocytes (TILs) and PD-1/PD-L1 immune checkpoints in human brain metastases
Patrick N Harter, Simon Bernatz, Alexander Scholz, et al.
Neuro-Oncology
|
February 24, 2016
A Phase II randomized study of galunisertib monotherapy or galunisertib plus lomustine compared with lomustine monotherapy in patients with recurrent glioblastoma
Alba A Brandes, Antoine F Carpentier, Santosh Kesari, et al.
Acta Neuropathologica
|
January 9, 2016
Erratum to: Gliomatosis cerebri: no evidence for a separate brain tumor entity
Ulrich Herrlinger, David T W Jones, Martin Glas, et al.
Acta Neuropathologica Communications
|
March 2, 2018
CD74 regulates complexity of tumor cell HLA class II peptidome in brain metastasis and is a positive prognostic marker for patient survival
P S Zeiner, J Zinke, D J Kowalewski, et al.
Journal of Neuro-Oncology
|
August 19, 2009
Imatinib in combination with hydroxyurea versus hydroxyurea alone as oral therapy in patients with progressive pretreated glioblastoma resistant to standard dose temozolomide
Gregor Dresemann, Michael Weller, Mark A Rosenthal, et al.
Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
|
January 17, 2025
Borderline Findings in <i>O</i>-(2-[<sup>18</sup>F]-Fluoroethyl)-l-Tyrosine PET of Patients with Suspected Glioma Relapse: Role in Clinical Practice
Karl-Josef Langen, Gabriele Stoffels, Christian P Filss, et al.
American Journal of Medical Genetics
|
January 1, 1981
The dup(3q) syndrome: report of eight cases and review of the literature
P Steinbach, W N Adkins, H Caspar, et al.
Page
of 37